Roadmap for Improving Patient and Graft Survival in the Next 10 Years

被引：21
作者：
Charlton, Michael R. [1 ]
机构：
[1] Intermt Med Ctr, Dept Hepatol, Liver Transplantat Program, 5169 South Cottonwood St, Murray, UT 84107 USA
来源：
LIVER TRANSPLANTATION | 2016年 / 22卷
关键词：
LIVER-TRANSPLANT RECIPIENTS; ONSET DIABETES-MELLITUS; TERM-FOLLOW-UP; RISK-FACTORS; METABOLIC SYNDROME; RENAL-FUNCTION; CRYPTOGENIC CIRRHOSIS; HEPATITIS-C; PREVALENCE; TACROLIMUS;
D O I：
10.1002/lt.24602
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S71 / S78
页数：8
相关论文
共 38 条
[1]   Evolution of liver transplantation in Europe: Report of the European liver transplant registry [J].
Adam, P ;
McMaster, P ;
O'Grady, JG ;
Castaing, D ;
Klempnauer, JL ;
Jamieson, N ;
Neuhaus, P ;
Lerut, J ;
Salizzoni, M ;
Pollard, S ;
Muhlbacher, F ;
Rogiers, X ;
Valdecasas, JCG ;
Berenguer, J ;
Jaeck, D ;
Gonzalez, EM .
LIVER TRANSPLANTATION, 2003, 9 (12) :1231-1243
[2]   Safety and Effectiveness of Ezetimibe in Liver Transplant Recipients with Hypercholesterolemia [J].
Almutairi, Fawaz ;
Peterson, Theresa C. ;
Molinari, Michele ;
Walsh, Mark J. ;
Alwayn, Ian ;
Peltekian, Kevork M. .
LIVER TRANSPLANTATION, 2009, 15 (05) :504-508
[3]   Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients [J].
Alvares-da-Silva, MR ;
da Silveira, TR .
NUTRITION, 2005, 21 (02) :113-117
[4]  
Åsberg A, 2003, DRUGS, V63, P367
[5]   Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].
Baid, S ;
Cosimi, AB ;
Farrell, ML ;
Schoenfeld, DA ;
Feng, S ;
Chung, RT ;
Tolkoff-Rubin, N ;
Pascual, M .
TRANSPLANTATION, 2001, 72 (06) :1066-1072
[6]   Metabolic Syndrome in Liver Transplantation: Relation to Etiology and Immunosuppression [J].
Bianchi, Giampaolo ;
Marchesini, Giulio ;
Marzocchi, Rebecca ;
Pinna, Antonio D. ;
Zoli, Marco .
LIVER TRANSPLANTATION, 2008, 14 (11) :1648-1654
[7]  
Canzanello V J, 1997, Liver Transpl Surg, V3, P1
[8]   Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial [J].
Cassiman, David ;
Roelants, Mieke ;
Vandenplas, Gerda ;
Van der Merwe, Schalk W. ;
Mertens, Ann ;
Libbrecht, Louis ;
Verslype, Chris ;
Fevery, Johan ;
Aerts, Raymond ;
Pirenne, Jacques ;
Muls, Erik ;
Nevens, Frederik .
TRANSPLANT INTERNATIONAL, 2006, 19 (12) :1000-1005
[9]   Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial [J].
De Simone, P. ;
Nevens, F. ;
De Carlis, L. ;
Metselaar, H. J. ;
Beckebaum, S. ;
Saliba, F. ;
Jonas, S. ;
Sudan, D. ;
Fung, J. ;
Fischer, L. ;
Duvoux, C. ;
Chavin, K. D. ;
Koneru, B. ;
Huang, M. A. ;
Chapman, W. C. ;
Foltys, D. ;
Witte, S. ;
Jiang, H. ;
Hexham, J. M. ;
Junge, G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) :3008-3020
[10]   Weight change and obesity after liver transplantation: Incidence and risk factors [J].
Everhart, JE ;
Lombardero, M ;
Lake, JR ;
Wiesner, RH ;
Zetterman, RK ;
Hoffnagle, JH .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04) :285-296
1234